Abstract:Objective:To compare the efficacy and safety of risperidone and chlorpromazine in treatment of first-episode schizo phrenia.Methods:It is a one year naturalistic study.One hundred and eighty-six patients with first-episode of schizophrenia were included who met ICD-10 criteria for schizophrenia or schizophreniform disorder and received integrated treatment(risper- idone or chlorpromazine plus psychosocial education,family psycho-education).There were 131 patients included in the risperi- done group and 55 included in the chlorpromazine group.Written informed consent was obtained from the patients or their legal guardians.Clinical stains was assessed with the Positive and Negative Symptom Scale(PANSS).the Treatment Emergent Symptom Scale(TESS)and the time to the discontinuation of treatment.The Short Form-36(sf-36)was used to assess the quality of life.Results:Thirty-five percent in the rieperdone group partially completed follow-up assessments and 51% in the chlor promazine group did.the difference of the rates between the two groups was significant.Response rate was defined as improvement in PANSS total score of≥50%.The response rates at the end of 2.3.6.8.12 months in the risperidone group were 29.1%.41.8%. 50.9%.50.9%.56.4% and in the chlorpromazine group were 40.5%.46.6%.57.3%.64.1%.62.6%.respectively.There was no significant difference of the response rate at any of the follow up time between the two groups.The relapse rates were similar as 20. 2% in the risperidone group and 20.6% in the comparing group.The time to the discontinuation of treatment for any cause was longer in the risperidone group than in the chlorpromazine gronp.However.the difference was not significant.Risperidone was associated with lower symptoms of tremor,constipation,sialorrhea(P0.01)and also associated with more frequent reports of agitation,de- pression,insomnia,gastrointestinal disturbance,menstrual disorder(P0.05).There are significant improvements in 6 factors (role of physics,body pain.globe health,social function,role of emotion and mental heahh)of sf 36 in risperidone group and only 2 factory(social function,role of emotion)in the comparative group.Conclusion:The efficacy of risperidone is as same as that of chlorpromazine in the treatment of first-episode schizophrenia,yet the rates of some adverse events are different in the two groups and risperidone may enhance the quality of life from more aspects.

Effect of MECT combined with Risperidone Oral Solution on irritability and agitation syndrome during the acute phase of schizophrenia

A double blinded multicenter clinical trial for evaluating the efficacy and safety of aripiprazole and risperidone in the treatment of schizophrenia

Efficacy and Safety of Long-Acting Risperidone on Early Onset Schizophrenia in Adolescent Patients

A Multicenter Study of Risperidone Treatment for Acute Agitation in Patients with Schizophrenia

A comparative study of the effect of modern electroconvulsive therapy on the agitated behavior of psychotic patients

Clinical Study of Risperidone Orally Disintegrating Tabiets and Clozapine in the Treatment of Schizophrenia

Double-blind,double-dummy and randomized controlled study of aripiprazole in the treatment of acute schizophrenia

Clinical effect of modified electroconvulsive therapy on schizophrenia

[Repetitive Transcranial Magnetic Stimulation Combined with Antidepressant Medication in Treatment of First-Episode Patients with Major Depression].

Study on Efficacy and Safety of Risperidone in Treatment of Different Kinds of Schizophrenia

A control study on short time using benzhexol impact on cognition function of schizophrenia treated with risperidone

Risperidone Versus Haloperidol in the Treatment of Acute Exacerbations of Chronic Inpatients with Schizophrenia: a Randomized Double-Blind Study

Efficacy and Safety of the Domestic Risperidone in Patients with Schizophrenia:a Randomized,Double-blind,Controlled Trial

Effect of aripiprazole on promoting cognitive function and enhancing clinical efficacy in patients with first-episode depression on escitalopram: A randomized controlled trial

Comparison the clinical effects and safety of amisulpride and risperidone in the treatment of schizophrenia

Comparative Study Between Etomidate and Propofol for Induction of Modified Electroconvulsive Therapy in Schizophrenic Patients

One Year Follow-up Study: Risperidone and Chlorpromazine for Patients with First-episode Schizophrenia

Efficacy and safety of modified electroconvulsive therapy with different electrode placement in the treatment of elderly patients with depression

Prescription Practices in the Treatment of Agitation in Newly Hospitalized Chinese Schizophrenia Patients: Data from a Non-Interventional Naturalistic Study

Role of Quetiapine Combined with Modified Electroconvulsive Therapy in Bipolar Depression

Aripiprazole and risperidone in treatment of the patients with schizophrenia: a randomly clinical trial